Table 2.

Probability of a dose exceeding a target response (adjusted for placebo) (mITT population)

UMEC dose	Probability (%) of exceeding a specified change from baseline FEV 1 at trough (Day 8 dataset)
	0.075 L	0.100 L	0.120 L	0.150 L
15.6 μg QD	43	21	11	3
31.25 μg QD	88	74	56	30
62.5 μg QD	95	87	77	52
125 μg QD	99	100	99	92
15.6 μg BID	89	75	59	33
31.25 μg BID	78	60	44	21

BID, twice daily; FEV₁, forced expiratory volume in 1 second; QD, once daily; UMEC, umeclidinium bromide.